Diagnosis and testing in bronchiolitis: a systematic review.

BACKGROUND The diagnosis of bronchiolitis is based on typical history and results of a physical examination. The indications for and utility of diagnostic and supportive laboratory testing (eg, chest x-ray films, complete blood cell counts, and respiratory syncytial virus testing) are unclear. OBJECTIVES To review systematically the data on diagnostic and supportive testing in the management of bronchiolitis and to assess the utility of such testing. DESIGN In conjunction with an expert panel, we generated admissibility criteria and derived relevant terms to search the literature published from 1980 to November 2002 in MEDLINE and the Cochrane Collaboration Database of Controlled Clinical Trials. Trained abstractors completed detailed data collection forms for each article. We summarized the data in tables after performing data integrity checks. RESULTS Of the 797 abstracts identified, we present evidence from 82 trials that met our inclusion criteria (17 are primary articles on diagnosis of bronchiolitis and 65are reports of treatment or prevention trials). Numerous studies demonstrate that rapid respiratory syncytial virus tests have acceptable sensitivity and specificity, but no data show that respiratory syncytial virus testing affects clinical outcomes in typical cases of the disease. Seventeen studies presented chest x-ray film data. Abnormalities on chest x-ray films ranged from 20% to 96%. Insufficient data exist to show that chest x-ray films reliably distinguish between viral and bacterial disease or predict severity of disease. Ten studies included complete blood cell counts, but most did not present specific results. In one study, white blood cell counts correlated with radiologically defined disease categories of bronchiolitis. CONCLUSIONS A large number of studies include diagnostic and supportive testing data. However, these studies do not define clear indications for such testing or the impact of testing on relevant patient outcomes. Given the high prevalence of this disease, prospective studies of the utility of such testing are needed and feasible.

[1]  B. Chipps A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, CONTROLLED TRIAL OF NEBULIZED EPINEPHRINE IN INFANTS WITH ACUTE BRONCHIOLITIS , 2004, Pediatrics.

[2]  K. Lohr,et al.  Pharmacologic treatment of bronchiolitis in infants and children: a systematic review. , 2004, Archives of pediatrics & adolescent medicine.

[3]  P. O’Rourke,et al.  A multicenter, randomized, double-blind, controlled trial of nebulized epinephrine in infants with acute bronchiolitis. , 2003, The New England journal of medicine.

[4]  R. Platt,et al.  A randomized, controlled trial of the effectiveness of nebulized therapy with epinephrine compared with albuterol and saline in infants hospitalized for acute viral bronchiolitis. , 2002, The Journal of pediatrics.

[5]  Pamela J Schoettker,et al.  Impact of a bronchiolitis guideline: a multisite demonstration project. , 2002, Chest.

[6]  W. Gruber,et al.  Illness severity, viral shedding, and antibody responses in infants hospitalized with bronchiolitis caused by respiratory syncytial virus. , 2002, The Journal of infectious diseases.

[7]  Kevin Purcell,et al.  Concurrent serious bacterial infections in 2396 infants and children hospitalized with respiratory syncytial virus lower respiratory tract infections. , 2002, Archives of pediatrics & adolescent medicine.

[8]  J. Avner,et al.  Management of fever in infants and children. , 2002, Emergency medicine clinics of North America.

[9]  P. Coyle,et al.  A comparison of nested polymerase chain reaction and immunofluorescence for the diagnosis of respiratory infections in children with bronchiolitis, and the implications for a cohorting strategy. , 2001, The Journal of hospital infection.

[10]  S. Horn,et al.  Effect of practice variation on resource utilization in infants hospitalized for viral lower respiratory illness. , 2001, Pediatrics.

[11]  Meissner Hc Uncertainty in the management of viral lower respiratory tract disease. , 2001 .

[12]  B. Rubin,et al.  Efficacy of recombinant human deoxyribonuclease I in the hospital management of respiratory syncytial virus bronchiolitis. , 2001, Chest.

[13]  I. Sánchez,et al.  Efficacy of nebulized epinephrine versus salbutamol in hospitalized infants with bronchiolitis , 2001, Pediatric pulmonology.

[14]  H. Atherton,et al.  Evaluation of an evidence-based guideline for bronchiolitis. , 1999, Pediatrics.

[15]  M. Harper,et al.  Low risk of bacteremia in febrile children with recognizable viral syndromes. , 1999, The Pediatric infectious disease journal.

[16]  M. Luchetti,et al.  Porcine‐derived surfactant treatment of severe bronchiolitis , 1998, Acta anaesthesiologica Scandinavica.

[17]  G. Marshall,et al.  Standardizing the care of bronchiolitis. , 1998, Archives of pediatrics & adolescent medicine.

[18]  D. Can,et al.  Salbutamol or mist in acute bronchiolitis , 1998, Acta paediatrica Japonica : Overseas edition.

[19]  N. Tordo,et al.  Detection of Respiratory Syncytial Virus A and B and Parainfluenzavirus 3 Sequences in Respiratory Tracts of Infants by a Single PCR with Primers Targeted to the L-Polymerase Gene and Differential Hybridization , 1998, Journal of Clinical Microbiology.

[20]  S. McMahon,et al.  The Use of Albuterol in Hospitalized Infants With Bronchiolitis , 1998, Pediatrics.

[21]  G. Swingler,et al.  Randomised controlled trial of clinical outcome after chest radiograph in ambulatory acute lower-respiratory infection in children , 1998, The Lancet.

[22]  W. Gruber,et al.  Respiratory syncytial virus immune globulin treatment of RSV lower respiratory tract infection in previously healthy children. , 1997, Pediatrics.

[23]  N. Kuppermann,et al.  Risks for bacteremia and urinary tract infections in young febrile children with bronchiolitis. , 1997, Archives of pediatrics & adolescent medicine.

[24]  K. De Boeck,et al.  Respiratory syncytial virus bronchiolitis: a double-blind dexamethasone efficacy study. , 1997, The Journal of pediatrics.

[25]  W. Gruber,et al.  Respiratory Syncytial Virus (RSV) Immune Globulin Intravenous Therapy for RSV Lower Respiratory Tract Infection in Infants and Young Children at High Risk for Severe RSV Infections , 1997 .

[26]  M. Saijo,et al.  White blood cell count, C‐reactive protein and erythrocyte sedimentation rate in respiratory syncytial virus infection of the lower respiratory tract , 1996, Acta paediatrica Japonica : Overseas edition.

[27]  E. Wang,et al.  Ribavirin for respiratory syncytial virus lower respiratory tract infection. A systematic overview. , 1996, Archives of pediatrics & adolescent medicine.

[28]  E. Wang,et al.  Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study of admission and management variation in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. , 1996, The Journal of pediatrics.

[29]  R. Tanz,et al.  Dexamethasone in bronchiolitis: a randomised controlled trial , 1996, The Lancet.

[30]  K. Menon,et al.  A randomized trial comparing the efficacy of epinephrine with salbutamol in the treatment of acute bronchiolitis. , 1995, The Journal of pediatrics.

[31]  A. Gadomski,et al.  Clinical trial of vitamin A as adjuvant treatment for lower respiratory tract infections. , 1995, The Journal of pediatrics.

[32]  Matthew Gelmini,et al.  Aerosolized ribavirin in mechanically ventilated children with respiratory syncytial virus lower respiratory tract disease: A prospective, double‐blind, randomized trial , 1994, Critical care medicine.

[33]  B. Chipps,et al.  Alpha-2A-interferon for treatment of bronchiolitis caused by respiratory syncytial virus. , 1993, The Pediatric infectious disease journal.

[34]  D. O’Connell,et al.  Treatment of acute bronchiolitis with Chinese herbs. , 1993, Archives of disease in childhood.

[35]  A. Patwari,et al.  Lower respiratory tract infection in hospitalized children due to respiratory syncytial (RS) virus during a suspected epidemic period of RS virus in Delhi. , 1992, Journal of tropical pediatrics.

[36]  T. Klassen,et al.  Randomized trial of salbutamol in acute bronchiolitis. , 1991, The Journal of pediatrics.

[37]  K N Shaw,et al.  Outpatient assessment of infants with bronchiolitis. , 1991, American journal of diseases of children.

[38]  H. Levison,et al.  Nebulized albuterol in acute bronchiolitis. , 1990, The Journal of pediatrics.

[39]  N. Mogridge,et al.  The chest radiograph in acute bronchiolitis , 1990, Journal of paediatrics and child health.

[40]  F. Shann,et al.  Clinical findings and severity of acute bronchiolitis , 1990, The Lancet.

[41]  S. Todd,et al.  Comparison of directigen RSV with viral isolation and direct immunofluorescence for the identification of respiratory syncytial virus , 1990, Journal of clinical microbiology.

[42]  J. Embree,et al.  Comparison of nasopharyngeal aspirate and nasopharyngeal swab specimens for respiratory syncytial virus diagnosis by cell culture, indirect immunofluorescence assay, and enzyme-linked immunosorbent assay , 1987, Journal of clinical microbiology.

[43]  P. Getson,et al.  Aerosolized ribavirin in the treatment of patients with respiratory syncytial virus disease , 1987, The Pediatric infectious disease journal.

[44]  R. Cornall,et al.  Ribavirin aerosol for acute bronchiolitis. , 1986, Archives of disease in childhood.

[45]  W. P. Glezen,et al.  Risk of primary infection and reinfection with respiratory syncytial virus. , 1986, American journal of diseases of children.

[46]  P. Krasilnikoff,et al.  Antibiotic treatment of pneumonia and bronchiolitis. A prospective randomised study. , 1984, Archives of disease in childhood.

[47]  V. Knight,et al.  Ribavirin aerosol treatment of bronchiolitis associated with respiratory syncytial virus infection in infants. , 1983, Pediatrics.

[48]  S. Court The definition of acute respiratory illnesses in children , 1973, Postgraduate medical journal.

[49]  S. Katz Infectious disease emergencies. , 1962, The Medical clinics of North America.

[50]  D. Shay,et al.  Bronchiolitis management preferences and the influence of pulse oximetry and respiratory rate on the decision to admit. , 2003, Pediatrics.

[51]  A. Coates,et al.  Efficacy of oral dexamethasone in outpatients with acute bronchiolitis. , 2002, The Journal of pediatrics.

[52]  H. Meissner Uncertainty in the management of viral lower respiratory tract disease. , 2001, Pediatrics.

[53]  D. Nakayama,et al.  Bronchial reactivity in infants in acute respiratory failure with viral bronchiolitis , 1989, Pediatric pulmonology.